Brent Saunders abruptly out as Bausch + Lomb CEO

· Health · United States

Bausch + Lomb announced that CEO Brent Saunders has left the company, describing the move as mutually agreed. The exit ends a three-year run for one of biopharma's most prominent dealmakers and highest-paid executives, who had been expected to deliver a multibillion-dollar sale of the eye-care company. No permanent successor was named in the statement. The sudden change at the top raises questions about the strategic direction of the contact-lens and eye-health business, which had been under pressure to improve performance and unlock value for shareholders. Saunders previously led Allergan and built a reputation for large-scale M&A.

Why it matters：Leadership turnover at a major eye-care company affects its pipeline, commercial partners and the wider expectation of consolidation in ophthalmology.

Key points

  • Saunders's departure was described in a statement as mutually agreed.
  • He is one of biopharma's most prominent dealmakers and highest-paid leaders.
  • No successor was named in the announcement.

Sources (original reporting)

More stories from this day